Overview

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy for the recovery of peripheral fat of lopinavir/ritonavir in monotherapy versus abacavir/lamivudine and lopinavir/ritonavir in subjects who developed lipoatrophy while receiving zidovudine plus lamivudine plus abacavir.
Phase:
Phase 4
Details
Lead Sponsor:
Fundacion SEIMC-GESIDA
Collaborator:
Abbott
Treatments:
Abacavir
Lamivudine
Lopinavir
Ritonavir